Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seiji Ueda

Showing results (101-110 of 124) with videos related to

Pageof 13
Sort By:
American Journal of Nephrology|August 15, 2008
Circulating matrix metalloproteinase-2 is an independent correlate of proteinuria in patients with chronic kidney diseaseMakio Nagano, Kei Fukami, Sho-ichi Yamagishi, et al.
Metabolism: Clinical and Experimental|July 17, 2009
Positive association of serum levels of advanced glycation end products and high mobility group box-1 with asymmetric dimethylarginine in nondiabetic chronic kidney disease patientsTsukasa Nakamura, Eiichi Sato, Nobuharu Fujiwara, et al.
Diabetes|May 1, 2013
DNA aptamer raised against AGEs blocks the progression of experimental diabetic nephropathyYusuke Kaida, Kei Fukami, Takanori Matsui, et al.
Pharmacological Research|May 20, 2009
Circulating levels of advanced glycation end products (AGE) and interleukin-6 (IL-6) are independent determinants of serum asymmetric dimethylarginine (ADMA) levels in patients with septic shockTsukasa Nakamura, Eiichi Sato, Nobuharu Fujiwara, et al.
Kidney International|October 11, 2013
Asymmetric dimethylarginine accumulates in the kidney during ischemia/reperfusion injuryYosuke Nakayama, Seiji Ueda, Sho-ichi Yamagishi, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|April 17, 2013
Effects of switching from calcium carbonate to lanthanum carbonate on bone mineral metabolism in hemodialysis patientsRie Manabe, Kei Fukami, Ryotaro Ando, et al.
Journal of the American Society of Nephrology : JASN|June 11, 2017
Asymmetric Dimethylarginine Contributes to the Impaired Response to Erythropoietin in CKD-AnemiaMiyuki Yokoro, Yosuke Nakayama, Sho-Ichi Yamagishi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 3, 2012
Experimental diabetic nephropathy is accelerated in matrix metalloproteinase-2 knockout miceYoshimi Takamiya, Kei Fukami, Sho-ichi Yamagishi, et al.
Clinical and Experimental Pharmacology & Physiology|June 10, 2010
Interstitial Foxp3-positive T cells may predict renal survival in patients with myeroperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritisJunko Yoshimura, Kei Fukami, Kiyomi Koike, et al.
Microvascular Research|July 30, 2018
Advanced glycation end products evoke inflammatory reactions in proximal tubular cells via autocrine production of dipeptidyl peptidase-4Kumiko Kaifu, Seiji Ueda, Nobutaka Nakamura, et al.
Pageof 13

Showing results (101-110 of 124) with videos related to

Sort By:
Pageof 13
American Journal of Nephrology|August 15, 2008
Circulating matrix metalloproteinase-2 is an independent correlate of proteinuria in patients with chronic kidney diseaseMakio Nagano, Kei Fukami, Sho-ichi Yamagishi, et al.
Metabolism: Clinical and Experimental|July 17, 2009
Positive association of serum levels of advanced glycation end products and high mobility group box-1 with asymmetric dimethylarginine in nondiabetic chronic kidney disease patientsTsukasa Nakamura, Eiichi Sato, Nobuharu Fujiwara, et al.
Diabetes|May 1, 2013
DNA aptamer raised against AGEs blocks the progression of experimental diabetic nephropathyYusuke Kaida, Kei Fukami, Takanori Matsui, et al.
Pharmacological Research|May 20, 2009
Circulating levels of advanced glycation end products (AGE) and interleukin-6 (IL-6) are independent determinants of serum asymmetric dimethylarginine (ADMA) levels in patients with septic shockTsukasa Nakamura, Eiichi Sato, Nobuharu Fujiwara, et al.
Kidney International|October 11, 2013
Asymmetric dimethylarginine accumulates in the kidney during ischemia/reperfusion injuryYosuke Nakayama, Seiji Ueda, Sho-ichi Yamagishi, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|April 17, 2013
Effects of switching from calcium carbonate to lanthanum carbonate on bone mineral metabolism in hemodialysis patientsRie Manabe, Kei Fukami, Ryotaro Ando, et al.
Journal of the American Society of Nephrology : JASN|June 11, 2017
Asymmetric Dimethylarginine Contributes to the Impaired Response to Erythropoietin in CKD-AnemiaMiyuki Yokoro, Yosuke Nakayama, Sho-Ichi Yamagishi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 3, 2012
Experimental diabetic nephropathy is accelerated in matrix metalloproteinase-2 knockout miceYoshimi Takamiya, Kei Fukami, Sho-ichi Yamagishi, et al.
Clinical and Experimental Pharmacology & Physiology|June 10, 2010
Interstitial Foxp3-positive T cells may predict renal survival in patients with myeroperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritisJunko Yoshimura, Kei Fukami, Kiyomi Koike, et al.
Microvascular Research|July 30, 2018
Advanced glycation end products evoke inflammatory reactions in proximal tubular cells via autocrine production of dipeptidyl peptidase-4Kumiko Kaifu, Seiji Ueda, Nobutaka Nakamura, et al.
Pageof 13